Blood Banking & Blood Products

Published by: Global Industry Analysts

Published: Feb. 1, 2007 - 626 Pages

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

Quantitative Techniques & Analytics

Product Definitions and Scope of Study

Blood Components and Plasma Products

Whole Blood & Cellular Components

WBCs

RBCs

Platelets

Plasma Fractions

Fresh Frozen Plasma

Albumin Fractions

Factor VIII

Factor IX and Factor IX Complex

Fibrin/Thrombin

Equipment, Blood Tests and Consumables

Automated Analyzers for Blood Analysis

Blood Tests

Consumables

II. EXECUTIVE SUMMARY

1. Market Overview

Healthcare Scares Propel the Market

Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts

Worldwide Blood Banking and Blood Products Market at a Glance

Current & Future Analysis

Analysis by Geographic Region

Analysis by Product Segment

World Blood Components and Plasma Market Analysis in Units

Table 1: World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 2: World 10-Year Perspective for Blood Components and Plasma by Region/Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World for Years 2001, 2006 & 2010 (includes corresponding Graph/Chart)

Red Blood Cells - A Key Blood Component and a Major Contributor

Table 3: World Recent Past, Current & Future Analysis for Red Blood Cells by Region/Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 4: World 10-Year Perspective for Red Blood Cells by Region/Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World for Years 2001, 2006 & 2010 (includes corresponding Graph/Chart)

2. Market Trends & Issues

New Infections - A Continuous Threat

Safety and Availability: The Core Issues

Decontamination: A Viable Process

New Processes for Safer Blood Supply

Innovative Procedures Help Blood Conservation

Autologous Transfusion Strapping up for High Growth

Enzyme Converted Cells Set to Rule the Industry

Blood Unavailability: Substitutes to the Rescue

Transfusions: Hospitals Making Way for Others

Computer Identification Helps Patients

SARS: A Case of Mistaken Identity?

Pooling: Economical HIV Testing

Private Cord Blood Banking: Flying High Despite Opposition

Automation of Blood Banking - Nearing the Efficiency Frontier?

Automated Instrumentation Taking the Front Seat

Table 5: World Market for Blood Bank Technology (2004): Percentage Value Breakdown of Revenues by Segment - Manual Blood Bag Systems, Automated Systems, Component Lab, Commercial Plasma, Blood Salvage and Pathogen Inactivation (includes corresponding Graph/Chart)

Table 6: World Market for Automated Collection of Blood Components using Apheresis Technology (2005): Percentage Breakdown by Revenues for Gambro, Baxter, Haemonetics, Fresenius and Others (includes corresponding Graph/Chart)

Plasma Market: Automation Making Inroads

The RBC Market - Slow to Catch Up

Automation of Testing - Yet to Mature

Automation to Suffice Shortage Problems

How Near to the Efficiency Frontier?

3. Product Overview

Blood Banking and Blood Products Industry

Blood Components and Plasma Products

Equipment, Blood Tests and Consumables

Automated Analyzers for Blood Analysis

Blood Tests

Consumables

Blood - A Primer

Ionic Structure

Blood Components and their Applications

Blood Constituents

Plasma

Table 7: World Recent Past, Current & Future Analysis for Plasma Products - Annual Sales in US$ Million for Years 2003 through 2010 (includes corresponding Graph/Chart)

Red Blood Cells (RBC)

Blood Count

Platelets

White Blood Cells (WBC)

Derivative Products of Blood or Plasma Fractions

Plasma Protein and Fractionation

The Need

Fresh Frozen Plasma

Other Plasma Fractions

Albumin Fractions

Albumin Usage Rising in Profile, Wastage Worries Run Deep

Factor VIII

Factor IX and Factor IX Complex

Fibrin/Thrombin

Consumption of Blood Based on Type of Surgery/ Accident (In Units)

Table 8: World Market for Plasma Derivatives (2005): Percentage Breakdown of Revenues by Region for US, Europe, Asia-Pacific, Latin America and Rest of World (includes corresponding Graph/Chart)

Table 9: World Market for Plasma Derivatives (2005): Percentage Breakdown of Revenues by Product for IVIG, Factor VIII, Albumin, Alpha-1, Fibrin, Factor IX, AT III and Others (includes corresponding Graph/Chart)

4. Blood Collection Methods

Banking the Natural Blood Resources

Blood Banks

Blood Banking

Blood Transfusion

Role of Blood Banks

Blood Donor: The Epicenter of the Process

Eligibility Criteria for the Donor

The Basics of Blood Donation - Myths Exploded & Other Facts

Collection Methods

Blood Donation: The Process

Types of Blood Donation

Directed Blood Donations

Autologous Blood Donation

Alternative Usage of Patient’s Own Blood

General Blood Donation

Hemodilution

Wound Drainage

Cell Saver

The Method

Blood Salvaging

Blood Collection Centers

Blood Collection Management System

A Historical Retrospective

Blood Collection Centers

Types of Blood Collection Centers

Cord Blood Banks

Profit Collection Centers

Military Blood Banks

Hospital Blood Banks

Community Blood Banks

Non-Profit Collection Centers

Blood Processing

Blood Typing

Rh Blood Group System

ABO Blood Group System

Blood Types and their Compatibility

Table 10: Occurrence of Blood Groups Worldwide (In %) (includes corresponding Graph/Chart)

Blood Test

Blood Culture

The Costs

5. The Changing Landscape of Transfusion Technologies & Tests

Blood Transfusion: A Backdrop

Massive Transfusion

Complications and Risks Due to Transfusion

Circulatory Overload

Graft Versus Host Disease (GVHD)

Haemolytic Transfusion Reactions

Iron Overload

Bacterial Contamination

Thrombophlebitis

Allergic Reactions

Air Embolism

Hyperkalaemia

Changing Role of Blood Banking Technology

6. Blood Transfusion: The Process, Tests/Technologies

Cross Matching

Blood Donor/Recipient Screening

Blood Typing

Leukoreduction

Leukocyte Reduction Specification Standards/Filters

Coombs Test

7. Alternatives to Blood Transfusion: A Real Threat to the Industry

Bloodless Surgery

Therapeutic Apheresis

Plasmapheresis

Plateletpheresis

Leukapheresis

Volume Expanders

Colloids

Albumin

Dextrans

Hydroxyethyl Starch

Crystalloids

Blood Growth Factor Therapies - Newer Alternatives to Transfusion

8. Blood Substitutes

Blood Substitutes Under Development by Manufacturers

Pipeline Update for Blood Substitutes & Alternatives

Synthetic Blood International’s Oxycyte™ Undergoes Phase II Clinical Trial

Maelor’s Volplex Sets Foot into the Brazilian Market

BioTime’s Hextend Receives Marketing Approval in Korea

Alliance Inks Licensing Deals to Market OXYGENT™

Gelatin-based Adhesives to Seal Growth of Blood Products

BioTime’s Hetacool Wins Major Research Grants from NIH

Sangart’s Hemospan™ Wins New Grant Funding for Phase II Trial

Synthetic Blood Manufacturers/Developers

Alliance Pharmaceuticals Corp. (USA)

Biopure Corporation (USA)

Enzon Pharmaceuticals (USA)

Hemosol Inc. (Canada)

Northfield Laboratories Inc. (USA)

Sangart Inc. (USA)

SONUS Pharmaceuticals, Inc. (USA)

Synthetic Blood International, Inc. (USA)

9. Product Introductions/Innovations

Dade Behring Launches the Quadriga BeFree System

Swedish Inventors Develop New Processing System

Canada Invents New Method for Monitoring Blood and Blood Products

Terumo Launches Improvised Bags For Safe Blood Collection

Haemonetics Launches Cymbal Automated Blood Collection System

Illinois Inventors Introduces New Systems to Prepare Blood Products

Abbott Unveils Two New Products for Blood Banks

Cell Robotics Introduces New Lasette P 200

Beckman’s COULTER® LH 750 Hematology Analyzers Hit the Market

Haemonetics Unveils MCS®+ - Improved Red Cell Collection Technology

Baxter Launches ALYX Component Collection System

Grifols’ DG Gel® Revolutionizes Column Agglutination

10. Product Introductions/Innovations in the Recent Past

BioMérieux Introduces DAVINCI®

Pall Develops Novel Blood Filtration Membrane

Hemotech Launches Blood Recycling Product

Greiner North America Innovates MiniCollect Tubes

BioLargo Rolls out BI2O-Sorb

Terumo Penpol Introduces Terumo Automatic Component Extractor

BD Obtains FDA Approval for New Blood Collection Kit

Horiba Introduces Compact Blood Component Analyzer

PreAnalytiX Introduces PAXgene System

HemaMetrics Releases Crit-Scan

Pall Unveils Filter Products

11. Products in Pipeline & Technology Update

From Clinical Trials to Clinics

Zyme Quest’s ECO Cells Set to Spike the Blood Supplies Worldwide

Cerus Receives CE Mark Approval for the Intercept Blood System for Platelets

Haemonetics Wins FDA Approval for the ACP 215 System

Biomerieux’ Polycarbonate BacT/ALERT Receives US FDA Clearance

Pall’s eBDS Receives Green Signal from FDA

CardioPAT™ Surgical Blood Salvage System Gearing up for A Launch

PCS® 2 - Set to Enhance Plasma Quality

Dade Behring’s D-Dimer Assay Strapping up for Roll Out

Waiting for Regulatory Go Ahead

Leukotrap from Pall - A vCJD Prion Filter

ThermoGenesis’ DAC - A Non Contact Blood Separator

Under Trial

Procleix® Tigris™ Improves Ultrio’s HIV, HCV and HBV Detection Time by 42%

Akers’ ANC Rapid Tests Accorded Priority Status

Navigant Biotechnologies Gets Additional $2 Million Funding From US DOD

Potential Applications Unravel

Cord Blood Provides New Solutions for Leukemia

Pluristem Upgrades Cord Blood Hematopoietic Stem Cells

12. Recent Industry Activity

SunTech Medical Group Acquires Empirical Technologies

Cord Blood America Acquires Cryobank

Cord Blood Acquires CorCell

Kalbe Acquires Stake in CyGenics’s Subsidiary CordLife Indonesia

Haemonetics to Take Over Arryx

Cryobanks International Signs Letters of Intent with MedStem Services

Cryobanks International Opens Cord Blood Stem Cell Bank

DomaniCell Initiates Family Cord Blood Banking Program in Hospitals

Cryobanks International Grants License for Cord Blood Processing System

Baxter to Sell Transfusion Therapies to an Investment Group

Community Blood Center Bags Contract

Wilkes Medical Center Grants License for SafeTrace Tx

Biosite Collaborates with HUG Research Hospital

Pliva Terminates Agreement with Mayne

Mississippi Blood Services Secures Contract

APL Partners with Omscan

DomaniCell Receives Stem Cell Banking License

ThermoGenesis Enters into an Agreement with Cord Blood Registry

ZLB Enters into Plasma Deal with BCA

ViaCell and Pall Secure FDA Approval for ViaCord® Collection Kit

Pall Secures Contract from NBS to Supply ‘Leukotrap’ Filtration System

Biotest and Sanquin to Form Joint Venture for Plasma Production

Consorta Signs Partnership Agreement with GSABC

Haemonetics Signs Supply Agreement with Canadian Blood Services

Haemonetics Extends the Agreement with American Red Cross

Novation and Abbott Enter into a Technology Agreement

Olympus Redefines the Agreement with Biotest

Cerus to Receive Marketing Rights over Baxter’s INTERCEPT Blood System

CyGenics to Establish a New Cord Blood Banking Company

UKCBB to Establish a Modern Laboratory in UMIC’s New CTF

St. John’s Medical Center Procures Wyndgate’s SafeTrace Tx

Florida`s Blood Centers Acquires South Florida Blood Banks

BioStem Takes Over Cryobanks International

FCBS Creates a Niche for itself by designing Cord Blood Stem Cells and Offers Public Donation Option

Pall Signs Sale Agreement with Green Cross for Blood Filters

TCBB Starts Collecting Donations for Cord Blood

Pall Received FDA Clearance to Market New Pall Acrodose™ PL System

CordLife Singapore Receives AABB Accreditation

ITL and ARC Enter into an Agreement for Blood Bank Equipment

NBA and UKT Merge to Form NHSBT

BioMérieux and ExonHit Extend Collaboration to Develop Blood Diagnostics

Wyndgate Signs Agreement with Cameron Hospital

Daxor’s Subsidiary Wins Corporate Blood Banking Contract from Taglich Brothers

Baxter and American Red Cross Enter Into Agreement

CSL Signs Agreement with National Blood Authority

Chiron Finds a South African Partner for Procleix® Tigris®

ThermoGenesis and BHHTI Jointly Market CryoSeal FS

Baxter and Cerus Enter into a Marketing Agreement

Haemonetics Signs Technology Alliance with ZLB Plasma Services

BioTime Collaborates with Summit Pharmaceuticals International Corp

SurgiLance Bags a Contract from America’s Blood Centers

Florida’s Blood Centers Acquire Lake Park-based South Florida Blood Banks

Global Med Technologies’ Division Signs Agreement with Hospital Partners of America

Radiometer America and Consorta Extend Blood-Gas Products Deal

Baxter's ALYX System Wins Medical Design Excellence Award

Terumo Corp. Ups Stake in Blood Bag Venture

Vita 34 International AG Takes over the Holdings of Corcell and Vita 34

CSL Acquires Aventis Behring

Medsurge Medical Products Corp. Buys Cryo Genomics

Haemonetics’ Acquisition of Harvest Technologies Expands Surgical Blood Salvage Portfolio

Chiron Buys out Prion Solutions

Celmed & Gambro Tie up for GvHD Prevention System

Chiron Grants NAT Licenses to LabCorp and German Red Cross

Sekisui Chemical Ventures into Chinese Blood Collection Market

Stratec and Biotest Partner on the Development of a Blood Grouping Analyzer

PRDT, ARC & Maco Pharma in a Strategic Alliance

Pall’s Enhanced Bacterial Detection System to be Marketed by Kawasumi

Baxter and Cerus Rope in Bioone Corp for Marketing Intercept

Chiron Partners with ZymeQuest

Pall Corporation Signs Agreement with Haemonetics Corporation

Immucor Set to Unfurl Galileo’s Potential Across World

Haemonetics Corporation & Hemosystem SA in a Marketing Alliance

Chiron’s Armor Strengthened with Infectio’s Rapid Bacterial Detection Licenses

Haemonetics, Braemed and Caster in a Marketing Agreement for Cell Saver® 5

Haemonetics Obtains Marketing Licenses for Crit Scan®

Lifebank Receives AABB Accreditation

Bayer Divests Plasma Products Business to NPS

ITL Receives FDA Clearance to Market SSK

ThermoGenesis’ DAC System Awaits FDA Approval

Chronix Biomedical Files Patent Approval for a New Diagnostic Test

ViaCell’s Selective Amplification™ Program Boosts Cord Blood Banks’ Productivity

CordLife Opens Second Cord Blood Banking Facility Singapore

PharmaStem Inks Multiple Licensing Deals for Cord blood Preservation Technologies

Novation Bags Big Ticket Deals for Blood Products

13. Strategic Corporate Developments in the Recent Past

Lifebank Signs Agreement with JGH

Pall Obtains FDA Approval for DONOR™ Blood Reinfusion System

Pall Receives FDA Approval to Sell New Blood Collection Product

Chiron Boosts Presence in Asia

New England Cord Blood Bank Starts Two Laboratories in Venezuela and Mexico

OGA, FemPartners and Viacord Proffer Umbilical Cord Blood Services

ZLB Bioplasma Buys Nabi’s Testing Laboratory and Antibody Collection Centers

Interaqua Acquires Imunna

Drew Scientific Purchases MWI

Formosa and Yung Shin Ink a Joint Venture Deal

Cordlife and Shenyang Xiehe Establish CordLife Xiehe

Altachem and Erdos-Cashmere Form Beijing Erdos Altachem Pharma Ltd

Pall Signs Development and Licensing Agreement with Viragen

Chiron Signs Licensing Agreement with Roche

Indian Government Makes Testing for Hepatitis C Virus in Blood Banks Obligatory

Biopool Merges with Xtrana Inc

V.I Technologies Extends Transfusion Plasma Contract with ANRC

New England Cord Blood Bank Commences Operations of a Cord Blood Bank in the UK

Bergen Brunswig Launches Pharmabid.com, an Auction Website for Blood Products

14. Focus on Select Global Players

Leading Blood Banks

America’s Blood Centers (US)

AABB (US)

American Red Cross (US)

Blood Bank of Alaska (US)

California Cryobank (US)

Children’s World Blood Bank (US)

Community Blood Bank (US)

CorCell Inc. (US)

Indian Red Cross Society (India)

Japan Red Cross (Japan)

LifeBank Cryogenics (Canada)

National Blood Foundation (US)

New England Cord Blood Bank, Inc. (US)

New York Blood Center (US)

Oklahoma Blood Institute (US)

Rajkot Voluntary Blood Bank (India)

The Cord Blood Registry (US)

Thomas Jefferson University Hospital Blood Bank (US)

VITA 34 AG (Germany)

Leading Players in Blood Bank Technology and Supplies

Baxter International Inc. (US)

Beckman Coulter Inc (US)

Becton Dickinson (US)

BioMérieux SA (France)

Chiron Corporation (US)

Chiron Blood Testing (US)

Daxor Corporation (US)

Fresenius Group (Germany)

Gambro (Sweden)

Gen-Probe Incorporated (US)

Global Med Technologies, Inc. (US)

Haemonetics (US)

Hemagen Diagnostics Inc. (US)

Immucor Inc. (US)

Innovative Technologies for Life Limited (Australia)

Kawasumi Laboratories, Inc. (Japan)

Lifebank Cryogenics Corp. (Canada)

Novation LLC (US)

Olympus America, Inc. (US)

Pall Corp (US)

Pathogen Removal and Diagnostic Technologies, Inc. (US)

PharmaStem Therapeutics, Inc. (US)

Radiometer America, Inc. (US)

Surgical Innovation Group Plc (UK)

Terumo (Japan)

ThermoGenesis Corp. (US)

ViaCell, Inc. (US)

ZLB Behring L.L.C. (US)

ZymeQuest, Inc. (USA)

15. Global Market Perspective

Table 11: World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 12: World Historic Review for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 13: World 20-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

Table 14: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 15: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 16: World Historic Review for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 17: World Historic Review for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 18: World 20-Year Perspective for Blood Components and Plasma Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

Table 19: World 20-Year Perspective for Blood Components and Plasma Products by Product Group - Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 1991, 1995, 2006 & 2010

Table 20: World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 21: World Historic Review for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 22: World 20-Year Perspective for Whole Blood & Cellular Components by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

Table 23: World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 24: World Historic Review for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 25: World 20-Year Perspective for Plasma Fractions by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

Table 26: World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 27: World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 28: World 20-Year Perspective for Equipment, Blood Tests and Other Consumables by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

A. Market Analysis

Current and Future Analysis

Historic Review

Key Trends/Facts

US Blood Collection & Supply Profile

Blood Group Distribution

Table 29: US Market for Blood Banking and Blood Products: Percentage Break up of Blood Group by Rh Factor (includes corresponding Graph/Chart)

Table 30: Percentage Break up of Rh Blood Types in the US by Racial Group

Blood Donated and Transfused Every Year

Males Form the Major Chunk of Donors

Declining Donor Population

Cost of Blood

SARS Scares: Blood Banks Feel the Heat

Whole Human Blood: Export-Import Scenario in the Recent Past

Table 31: US Market for Whole Human Blood (2003 & 2004): Percentage Volume & Value Breakdown of Export by Country for France, Canada, United Kingdom, Germany, Japan, Taiwan, Korea, Belgium, The Netherlands, Italy, Peru, and Others (includes corresponding Graph/Chart)

Table 32: US Market for Whole Human Blood (2003 & 2004): Percentage Volume & Value Breakdown of Import for Consumption by Country for Japan, United Kingdom, Germany, Indonesia, and Canada (includes corresponding Graph/Chart)

US Blood Components and Plasma Market Analysis in Units

Table 33: US Recent Past, Current & Future Analysis for Blood Components and Plasma by Product Category - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 34: US 10-Year Perspective for Blood Components and Plasma by Product Category - Percentage Breakdown of Volume Consumption for Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2001, 2006 & 2010 (includes corresponding Graph/Chart)

Product Introductions/Innovations

Product Introductions/Innovations in the Recent Past

Recent Industry Activity

Strategic Corporate Developments in the Recent Past

Focus on Select Players

Blood Banks

Blood Bank Technology Developers and Consumables Suppliers

B. Market Analytics

Table 35: US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 36: US Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 37: US 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

2. Canada

A. Market Analysis

Current and Future Analysis

Historic Review

The ‘CSA-Z902-04’ - A New Comprehensive Voluntary Blood Safety Standard

LifeBank Cryogenics - The Only AABB Accredited Cord blood Stem Cell Bank

Recent Industry Activity

Strategic Corporate Developments in the Recent Past

Product Innovation

Product Introduction in the Recent Past

Lifebank Cryogenics Corp. - A Key Player

B. Market Analytics

Table 38: Canadian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 40: Canadian 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

3. Japan

A. Market Analysis

Un Upwardly Spiraling Market for FFP

Current and Future Analysis

Historic Review

Product Launch

Product Introduction in the Recent Past

Recent Industry Activity

Focus on Select Players

B. Market Analytics

Table 41: Japanese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 42: Japanese Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 43: Japanese 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

4. Europe

A. Market Analysis

Current & Future Analysis

Analysis by Geographic Region

European Blood Banking and Blood Products Market at a Glance (All figures are 2004 estimates & CAGR is for the period 2001-2010)

Analysis by Product Segment

Historic Review

Analysis by Geographic Region

Analysis by Product Segment

Industry Trends and Issues

Legislations on Payment for Donation Restrict Donors

Lack of Proper Facilities Hamper Production of Plasma Products

Government’s Check on Healthcare Costs Pressurizes BCT Manufacturers

Grim Scenario for Manufacturers as Purchasing System Witnesses Modifications

EU Nations Marching Towards Self-Sufficiency in Blood and Blood Products

Factors Driving the Market

Cautious Mood of Customers Drives Blood Collection Devices Market

Elders Remain Primary Demand Drivers

Innovative Technologies on the Horizon

New EU Implementations Spell Opportunity for Blood Banking Industry

Factors Restraining the Market

Innovative Surgical Processes Put Blood Loss and Blood Replacement to a Minimum

Blood Substitutes - Industry’s Answer to Supply Shortages

A Snapshot of Health Care Systems Across Select EU Countries

France

Germany

Italy

The UK

Spain

Product Introductions/Innovations

Recent Industry Activity

Focus on Select Players

BioMérieux SA (France)

Fresenius Group (Germany)

Gambro (Sweden)

Surgical Innovation Group Plc (UK)

B. Market Analytics

Table 44: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 45: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 46: European Historic Review for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 47: European Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 48: European 20-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

Table 49: European 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

4a. France

A. Market Analysis

Current and Future Analysis

Competitive Scenario in the Recent Past

Table 50: Leading Players in the French Blood Banking Devices and Plasma Products Market (2003 & 2004) - Percentage Breakdown by Revenues for Kedrion, Baxter, and Others (includes corresponding Graph/Chart)

Historic Review

B. Market Analytics

Table 51: French Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 52: French Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 53: French 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

4b. Germany

A. Market Analysis

Current and Future Analysis

Competitive Scenario in the Recent Past

Table 54: Leading Players in the German Blood Banking Devices and Plasma Products Market (2003 & 2004) - Percentage Breakdown by Revenues for ZLB Behring, Baxter, Bayer and Others (includes corresponding Graph/Chart)

Historic Review

B. Market Analytics

Table 55: German Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 56: German Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 57: German 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

4c. Italy

A. Market Analysis

Current and Future Analysis

Historic Review

B. Market Analytics

Table 58: Italian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 59: Italian Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 60: Italian 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

4d. United Kingdom

A. Market Analysis

Current and Future Analysis

Competitive Scenario in the Recent Past

Table 61: Leading Players in the UK Blood Banking Devices and Plasma Products Market (2003 & 2004) - Percentage Breakdown by Revenues for Bio Products Laboratory, Baxter, Grifols and Others (includes corresponding Graph/Chart)

Historic Review

B. Market Analytics

Table 62: UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 63: UK Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 64: UK 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

4e. Spain

A. Market Analysis

Current and Future Analysis

Competitive Scenario in the Recent Past

Table 65: Leading Players in the Spanish Blood Banking Devices and Plasma Products Market (2003 & 2004) - Percentage Breakdown by Revenues for Baxter, Grifols, ZLB Behring and Others (includes corresponding Graph/Chart)

Historic Review

Strategic Development in the Recent Past

B. Market Analytics

Table 66: Spanish Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 67: Spanish Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 68: Spanish 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

4f. Russia

A. Market Analysis

Current and Future Analysis

Historic Review

B. Market Analytics

Table 69: Russian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 70: Russian Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 71: Russian 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

4g. Rest of Europe

A. Market Analysis

Current and Future Analysis

Historic Review

Developments in Recent Past

B. Market Analytics

Table 72: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 73: Rest of Europe Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 74: Rest of Europe 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

5. Asia-Pacific

A. Market Analysis

Current and Future Analysis

Historic Review

ASEAN - Striding Towards Standardization of Blood Supply

China -A Key Market

Government Wakes Up to Realities

Table 75: Chinese Market for Blood Banking and Blood Products: Percentage Share Breakdown by Type of Blood Groups (includes corresponding Graph/Chart)

Table 76: Chinese Market for Blood Banking and Blood Products: Percentage Share Breakdown of Blood Donor by Gender

Table 77: Chinese Blood Banking and Blood Products Market: Percentage Share Breakdown of Blood Donor by Age Group (includes corresponding Graph/Chart)

Recent Industry Activity

Strategic Corporate Developments in the Recent Past

Product Introduction in Recent Past

Focus on Select Players

Indian Red Cross Society (India)

Rajkot Voluntary Blood Bank (India)

B. Market Analytics

Table 78: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 79: Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 80: Asia-Pacific 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

6. Latin America

A. Market Analysis

Current and Future Analysis

Historic Review

B. Market Analytics

Table 81: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 82: Latin American Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 83: Latin American 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

7. Rest of World

A. Market Analysis

Current and Future Analysis

Historic Review

B. Market Analytics

Table 84: Rest of World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 85: Rest of World Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 86: Rest of World 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

IV. COMPETITION

1. AABB - American Association Of Blood Banks (USA)

2. Abbott Laboratories (USA)

Table 87: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 88: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 89: Nine Months Sales Analysis by Business Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 90: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 91: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 92: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million)

Table 93: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

Abbott Diagnostics Division of Abbott Laboratories (USA)

3. Advanced Biotechnologies, Inc. (USA)

4. Advanced Medical Supplies Ltd. (UK)

5. America’s Blood Centers (USA)

Blood Bank of Alaska (USA)

Community Blood Bank (USA)

6. American Red Cross (USA)

7. Analis SA/NV (Belgium)

8. Arkios Biodevelopment International (USA)

9. Baxter International, Inc. (USA)

Table 94: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 95: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 96: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 97: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 98: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 99: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 100: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 101: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

Baxter Healthcare (Asia) Pte., Ltd. (Singapore)

10. Beckman Coulter, Inc. (USA)

Table 102: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 103: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 104: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 105: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 106: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 107: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

Beckman Coulter GmbH (Germany)

11. Becton Dickinson and Company (USA)

Table 108: Annual Sales Analysis: 2004-2006 (In US$ million)

Table 109: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million)

Table 110: Annual Sales Analysis by Segment: 2005-2006 (In US$ million)

Table 111: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million)

Table 112: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 113: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 114: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

12. Beijing Hi-Inc. Health Technology Incubator (China)

13. BelReas Ltd. (Belarus)

14. Bio Products Laboratory (UK)

15. BioCare Corporation (Taiwan)

16. Biocell Laboratories, Inc. (USA)

17. BioMerieux SA (France)

Table 115: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In € million)

Table 116: Annual Sales Analysis: 2004-2005 (In € million)

Advanced Bioscience Laboratories, Inc. (USA)

18. Biopure Corporation (USA)

Table 117: Annual Sales Analysis: 2004-2006 (In US$ thousands)

Table 118: Annual Sales Analysis by Operation: 2004-2005 (In US$ thousands)

Table 119: Annual Sales Analysis by Quarter: 2004-2005 (In US$ thousands)

19. Bio-Rad Laboratories, Inc. (USA)

Table 120: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

Table 121: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million)

Table 122: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 123: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 124: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 125: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

20. Biosystems SA (Spain)

21. Biotec Laboratories Ltd. (UK)

22. Biotest AG (Germany)

Biotest Pharma GmbH (Germany)

23. BioTime, Inc. (USA)

Table 126: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ thousands)

Table 127: Annual Sales Analysis: 2004-2005 (In US$ thousands)

Table 128: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ thousands)

24. Blood Bank Of The Redwoods (USA)

25. Borolabs Ltd. (UK)

26. Braemed Ltd. (Canada)

27. California Cryobank (USA)

28. Canadian Blood Services (Canada)

29. Cangene Corporation (Canada)

Table 129: First Quarter Sales Analysis: 2006-2007 (In Can$ million)

Table 130: Annual Sales Analysis: 2005-2006 (In Can$ million)

Table 131: Annual Sales Analysis by Quarter: 2005-2006 (In Can$ million)

Table 132: Annual Sales Analysis by Segment: 2005-2006 (In Can$ million)

Table 133: Annual Sales Analysis by Geographic Region: 2005-2006 (In Can$ million)

30. Caster Medical Systems (Canada)

31. Cell Robotics International, Inc. (USA)

32. Central Blood Bank (CBB) (USA)

33. Cerus Corporation (USA)

Table 134: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ thousands)

Table 135: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ thousands)

Table 136: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ thousands)

Table 137: Annual Sales Analysis: 2004-2005 (In US$ thousands)

Table 138: Annual Sales Analysis by Quarter: 2004-2005 (In US$ thousands)

Table 139: Annual Sales Analysis by Segment: 2004-2005 (In US$ thousands)

34. Charter Medical Ltd. (USA)

35. Children's World Blood Bank (USA)

36. Chiron Corporation (USA)

Table 140: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 141: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 142: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 143: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

Chiron Blood Testing (USA)

37. CorCell, Inc. (USA)

38. Cord Blood Donor Foundation (USA)

39. Cryobanks International, Inc. (USA)

40. Cryo-Cell International, Inc. (USA)

Table 144: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, August) (In US$ million)

Table 145: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, August) (In US$ million)

Table 146: Annual Sales Analysis: 2004-2005 (In US$ million)

41. Cryocord Sdn Bhd (Malaysia)

42. CRH Medical Corporation (USA)

43. CSL Ltd. (Australia)

CSL Behring (USA)

44. Cygenics Limited (Australia)

45. Daxor Corporation (USA)

Table 147: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 148: Nine Months Sales Analysis by Business Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 149: Annual Sales Analysis: 2004-2005 (In US$ million)

Idant Laboratories (USA)

46. Dionex (UK) Ltd. (UK)

47. Dr. Bruno Lange GmbH & Co., KG. (Germany)

48. Eastern Medikit Limited (India)

49. EKF-Diagnostic GmbH (Germany)

50. Enzon Pharmaceuticals, Inc. (USA)

Table 150: First Quarter Sales Analysis: 2005-2006 (In US$ million)

Table 151: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 152: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 153: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million)

Table 154: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

51. Eppendorf AG (Germany)

Table 155: Annual Sales Analysis: 2004-2005 (In € million)

52. EVBB (USA)

53. Florida Georgia Blood Alliance (USA)

54. Florida’s Blood Centers (USA)

South Florida Blood Banks (SFBB) (USA)

55. Fresenius AG (Germany)

Table 156: Half Yearly Sales Analysis: 2005-2006 (H1) (In € billion)

Table 157: Half Yearly Sales Analysis by Business Segment: 2005-2006 (H1) (In € billion)

Table 158: Half Yearly Sales Analysis By Geographic Region: 2005-2006 (H1) (In € billion)

Table 159: Annual Sales Analysis: 2004-2005 (In € billion)

Table 160: Annual Sales Analysis by Business Segment: 2004-2005 (In € billion)

Table 161: Annual Sales Analysis By Geographic Region: 2004-2005 (In € billion)

56. Fujirebio, Inc. (Japan)

57. Gali Srl (Italy)

58. Gambro AB (Sweden)

Table 162: First Quarter Sales Analysis by Segment: 2005-2006 (In SEK million)

Table 163: Annual Sales Analysis: 2004-2005 (In SEK million)

Table 164: Annual Sales Analysis by Segment: 2004-2005 (In SEK million)

Table 165: Annual Sales Analysis by Geographic Region: 2004-2005 (In SEK million)

59. GEA Diessel GmbH (Germany)

60. Gen-Probe, Inc. (USA)

Table 166: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 167: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 168: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 169: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 170: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

61. Global Med Technologies, Inc. (USA)

Wyndgate Technologies (USA)

62. Grifols SA (Spain)

63. Haemonetics Corporation (USA)

Table 171: Half Yearly Sales Analysis: 2006-2007 (H1) (In US$ million)

Table 172: Half Yearly Sales Analysis by Geographic Region: 2006-2007 (H1) (In US$ million)

Table 173: Annual Sales Analysis: 2005-2006 (In US$ million)

Table 174: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million)

Table 175: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million)

64. Hema Metrics Corporation (USA)

65. HemaCare Corporation (USA)

Table 176: First Quarter Sales Analysis: 2005-2006 (In US$ million)

Table 177: First Quarter Sales Analysis by Business Segment: 2005-2006 (In US$ million)

Table 178: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 179: Quarterly Sales Analysis: 2004-2005 (In US$ million)

Table 180: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million)

66. Hemagen Diagnostics, Inc. (USA)

Table 181: Annual Sales Analysis: 2004-2006 (In US$ million)

Table 182: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million)

Table 183: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

67. Hema-Quebec (Canada)

Table 184: Annual Sales Analysis: 2004-2006 (In US$ million)

68. HemoCue AB (Sweden)

69. Hemosphere, Inc. (USA)

70. Hemosystem SA (France)

71. Home Diagnostics, Inc. (USA)

72. Immucor, Inc. (USA)

Table 185: Half Yearly Sales Analysis: 2006-2007 (H1) (In US$ million)

Table 186: Half Yearly Sales Analysis by Geographic Region: 2006-2007 (H1) (In US$ million)

Table 187: Annual Sales Analysis: 2004-2006 (In US$ million)

Table 188: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million)

Table 189: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million)

Table 190: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 191: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

73. Indian Red Cross Society (India)

74. Indiana Blood Center (USA)

75. Interlab D.O.O (Yugoslavia)

76. ITL Corporation Pty., Ltd. (Australia)

77. Japan Red Cross (Japan)

78. Jeevan Blood Bank (India)

79. Kaketsuken (Japan)

80. Kawasumi Laboratories, Inc. (Japan)

Table 192: Annual Sales Analysis: 2004-2006 (In ¥ million)

Table 193: Annual Sales Analysis by Geographic Region: 2005-2006 (In ¥ million)

Kawasumi Laboratories, Inc. (USA)

81. Kedrion SpA (Italy)

82. Laboratory Corporation of America Holdings (USA)

Table 194: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 195: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 196: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 197: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 198: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million)

83. Lampire Biological Laboratories, Inc. (USA)

84. Lifebank Corporation (Canada)

Table 199: Annual Sales Analysis: 2005-2006 (In Can$ thousands)

Table 200: Annual Sales Analysis: 2004-2005 (In Can$ thousands)

85. LifebankUSA (USA)

86. London Health Sciences Centre (Canada)

Table 201: Annual Sales Analysis: 2004-2005 (In Can$ million)

87. Macopharma SA (France)

88. Marcel Sp. z o.o. (Poland)

89. Medipurpose Pte., Ltd. (Singapore)

90. Memorial Blood Centers (USA)

91. Monobind, Inc. (USA)

92. National Blood Authority (Australia)

Table 202: Annual Sales Analysis: 2004-2005 (In A$ million)

93. National Blood Foundation (USA)

94. National Blood Service (UK)

95. New England Cord Blood Bank, Inc. (USA)

96. New York Blood Center (USA)

97. Northfield Laboratories, Inc. (USA)

98. Nova Biomedical (USA)

99. Novation (USA)

100. NPS Biotherapeutics, Inc. (USA)

101. Oklahoma Blood Institute (USA)

102. Olympus America, Inc. (USA)

103. Orsense (Israel)

104. Pall Corporation (USA)

Table 203: First Quarter Sales Analysis: 2006-2007 (In US$ million)

Table 204: First Quarter Sales Analysis by Business Segment: 2006-2007 (In US$ million)

Table 205: First Quarter Sales Analysis by Geographic Region: 2006-2007 (In US$ million)

Table 206: Annual Sales Analysis: 2005-2006 (In US$ million)

Table 207: Quarterly Sales Analysis: 2005-2006 (In US$ million)

Table 208: Annual Sales Analysis By Business Segment: 2005-2006 (In US$ million)

Table 209: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million)

105. Pathogen Removal and Diagnostic Technologies, Inc. (USA)

106. Pharmastem Therapeutics, Inc. (USA)

107. Pooja Blood Bank (India)

108. Prathama Blood Centre (India)

109. ProMetic Life Sciences, Inc. (Canada)

Table 210: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In Can$ million)

Table 211: Annual Sales Analysis: 2004-2005 (In Can$ million)

110. Puget Sound Blood Center (USA)

111. Radiometer America, Inc. (USA)

112. Rajkot Voluntary Blood Bank (India)

113. Reliance Life Sciences (India)

114. Research Triangle Park (USA)

115. Roche Instrument Center AG (Switzerland)

116. Sangart, Inc. (USA)

117. Sekisui Chemical Co., Ltd. (Japan)

Table 212: Annual Sales Analysis: 2005-2006 (In ¥ million)

Table 213: Annual Sales Analysis by Business Segment: 2005-2006 (In ¥ million)

Beijing Sekisui Trank Medical Technology Co., Ltd. (China)

118. Serum Biotec Ltd. (India)

119. Sigma-Aldrich Corporation (USA)

Table 214: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 215: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 216: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 217: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 218: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 219: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 220: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

120. Sonus Pharmaceuticals, Inc. (USA)

121. South African National Blood Service (South Africa)

122. Statens Serum Institute (Denmark)

Table 221: Annual Sales Analysis: 2004-2005 (In DKK million)

Table 222: Annual Sales Analysis by Segment: 2004-2005 (In DKK million)

123. Stratec Biomedical Systems AG (Germany)

Table 223: Annual Sales Analysis: 2004-2005 (In € million)

124. Sumitomo Corporation (Japan)

Table 224: First Quarter Sales Analysis: 2006-2007 (In ¥ billion)

Table 225: Annual Sales Analysis: 2004-2006 (In ¥ billion)

Table 226: Annual Sales Analysis by Segment: 2005-2006 (In ¥ billion)

Table 227: Annual Sales Analysis by Geographic Region: 2005-2006 (In ¥ billion)

Table 228: Annual Sales Analysis by Segment: 2004-2005 (In ¥ billion)

Table 229: Annual Sales Analysis by Geographic Region: 2004-2005 (In ¥ billion)

125. Summit Pharmaceuticals International Corporation (Japan)

126. Suncoast Communities Blood Bank (USA)

127. Surgical Innovations Group (UK)

Table 230: Annual Sales Analysis: 2004-2005 (In £ million)

128. Suru International Pvt., Ltd. (India)

129. Synthetic Blood International, Inc. (USA)

130. Taglich Brothers, Inc. (USA)

131. Talecris Biotherapeutics (USA)

132. Terumo Corporation (Japan)

Table 231: Annual Sales Analysis: 2004-2006 (In ¥ billion)

Table 232: Annual Sales Analysis by Segment: 2005-2006 (In ¥ billion)

Table 233: Annual Sales Analysis by Geographic Region: 2005-2006 (In ¥ billion)

Table 234: Annual Sales Analysis by Segment: 2004-2005 (In ¥ billion)

Table 235: Annual Sales Analysis by Geographic Region: 2004-2005 (In ¥ billion)

Terumo Medical Corporation (USA)

Terumo Penpol Limited (India)

133. The Cord Blood Registry (USA)

134. The University Of Colorado Cord Blood Bank (USA)

135. Thermo Fisher Scientific, Inc. (USA)

Table 236: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 237: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 238: Annual Sales Analysis: 2004-2005 (In US$ million)

136. ThermoGenesis Corporation (USA)

Table 239: First Quarter Sales Analysis: 200-2007 (In US$ million)

Table 240: Annual Sales Analysis: 2004-2006 (In US$ million)

137. Thomas Jefferson University Hospital Blood Bank (USA)

138. Two-Dimensional Instruments LLC (USA)

139. United Blood Services (USA)

140. VI Technology, Inc. (USA)

141. ViaCell, Inc. (USA)

Table 241:Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 242: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 243: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 244: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

ViaCord (USA)

142. Vita 34 AG (Germany)

143. Welsh Blood Service (UK)

144. ZymeQuest, Inc. (USA)

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.